Search research articles
Contact Us
Filters
Showing results (1-10 of 39) with videos related to
Page
of 4
Sort By:
Expert Review of Clinical Pharmacology
|
August 8, 2025
Confounding adjustment with propensity scores for overlap weighting in observational studies: a concise primer
John G Rizk
Journal of Clinical Epidemiology
|
August 24, 2025
When and Why to Use Overlap Weighting: Clarifying Its Role, Assumptions, and Estimand in Real-World Studies
John G Rizk
Journal of Clinical Epidemiology
|
June 15, 2026
When the Interruption Is Interrupted: Challenges in Applying Interrupted Time Series Analyses to Contemporary Pharmaceutical Policy Evaluations
John G Rizk
BMJ Evidence-Based Medicine
|
April 22, 2022
FDA's dilemma with the aducanumab approval: public pressure and hope, surrogate markers and efficacy, and possible next steps
John G Rizk, John C Lewin
Journal of Health Care for the Poor and Underserved
|
November 7, 2022
County-Level COVID-19 Vaccination Rates, Non-Communicable Diseases, and Socioeconomic Inequities: Applying Syndemic Theory to Vaccines
John G Rizk, Fadia T Shaya
JAMA Network Open
|
May 22, 2026
The Unfinished Science of Boxed Drug Warnings
John G Rizk, John C Lewin
Journal of Managed Care & Specialty Pharmacy
|
March 26, 2026
Transparent reporting of group-based trajectory modeling to study medication adherence: Practical considerations and common pitfalls
John G Rizk, Danya M Qato
Minerva Cardiology and Angiology
|
October 29, 2021
Thromboprophylaxis in outpatients with COVID-19: a safe bet or tilting at windmills?
John G Rizk, Giuseppe Lippi, Youssef Rizk
Journal of Clinical Epidemiology
|
December 18, 2025
Beautiful weights, misinterpreted effects: the use and misuse of overlap weighting in major medical journals, 2020-2025
John G Rizk, Giuseppe Lippi, Carl J Lavie
Expert Opinion on Investigational Drugs
|
June 30, 2021
Low-dose aspirin for early COVID-19: does the early bird catch the worm?
John G Rizk, Carl J Lavie, Ajay Gupta
Page
of 4
Search research articles
Search
Showing results (1-10 of 39) with videos related to
Sort By:
Page
of 4
Expert Review of Clinical Pharmacology
|
August 8, 2025
Confounding adjustment with propensity scores for overlap weighting in observational studies: a concise primer
John G Rizk
Journal of Clinical Epidemiology
|
August 24, 2025
When and Why to Use Overlap Weighting: Clarifying Its Role, Assumptions, and Estimand in Real-World Studies
John G Rizk
Journal of Clinical Epidemiology
|
June 15, 2026
When the Interruption Is Interrupted: Challenges in Applying Interrupted Time Series Analyses to Contemporary Pharmaceutical Policy Evaluations
John G Rizk
BMJ Evidence-Based Medicine
|
April 22, 2022
FDA's dilemma with the aducanumab approval: public pressure and hope, surrogate markers and efficacy, and possible next steps
John G Rizk, John C Lewin
Journal of Health Care for the Poor and Underserved
|
November 7, 2022
County-Level COVID-19 Vaccination Rates, Non-Communicable Diseases, and Socioeconomic Inequities: Applying Syndemic Theory to Vaccines
John G Rizk, Fadia T Shaya
JAMA Network Open
|
May 22, 2026
The Unfinished Science of Boxed Drug Warnings
John G Rizk, John C Lewin
Journal of Managed Care & Specialty Pharmacy
|
March 26, 2026
Transparent reporting of group-based trajectory modeling to study medication adherence: Practical considerations and common pitfalls
John G Rizk, Danya M Qato
Minerva Cardiology and Angiology
|
October 29, 2021
Thromboprophylaxis in outpatients with COVID-19: a safe bet or tilting at windmills?
John G Rizk, Giuseppe Lippi, Youssef Rizk
Journal of Clinical Epidemiology
|
December 18, 2025
Beautiful weights, misinterpreted effects: the use and misuse of overlap weighting in major medical journals, 2020-2025
John G Rizk, Giuseppe Lippi, Carl J Lavie
Expert Opinion on Investigational Drugs
|
June 30, 2021
Low-dose aspirin for early COVID-19: does the early bird catch the worm?
John G Rizk, Carl J Lavie, Ajay Gupta
Page
of 4